ArticleCNS neuroscience & therapeutics2014

BASI, a potent small molecular inhibitor, inhibits glioblastoma progression by targeting microRNA-mediated β-catenin signaling.

Zhen-Dong Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.